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Dusp6Fibroblast growth factors (FGFs) are secreted molecules that activate the RAS/mitogen-activated protein
kinase (MAPK) signaling pathway. In zebraﬁsh development, FGF signaling is responsible for establishing
dorsal polarity, maintaining the isthmic organizer, and cardiac ventricle formation. Because several ETS
factors are known transcriptional mediators of MAPK signaling, we hypothesized that these factors function
to mediate FGF signaling processes. In zebraﬁsh, the simultaneous knock-down of three Pea3 ETS proteins,
Etv5, Erm, and Pea3, produced phenotypes reminiscent of embryos deﬁcient in FGF signaling. Morphant
embryos displayed both cardiac and left/right patterning defects as well as disruption of the isthmic
organizer. Furthermore, the expression of FGF target genes was abolished in Pea3 ETS depleted embryos. To
understand how FGF signaling and ETS factors control gene expression, transcriptional regulation of dusp6
was studied in mouse and zebraﬁsh. Conserved Pea3 ETS binding sites were identiﬁed within the Dusp6
promoter, and reporter assays showed that one of these sites is required for dusp6 induction by FGFs. We
further demonstrated the interaction of Pea3 ETS factors with the Dusp6 promoter both in vitro and in vivo.
These results revealed the requirement of ETS factors in transducing FGF signals in developmental processes.and Molecular Genetics, 3501
urgh, PA 15213, USA.
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Fibroblast growth factors (FGFs) are a family of 22 proteins in
humans that are critical for proper development (Furthauer et al., 2004;
Itoh, 2007; Ornitz and Itoh, 2001; Sekine et al., 1999; Sun et al., 1999).
FGFs bind to a family of four receptor tyrosine kinases (FGFRs), which
initiate several signaling cascades, including the rat sarcomahomologue
(RAS)/mitogen-activated protein kinase (MAPK) cascade. Within this
signaling arm, activation of a MAPK protein, extracellular signal-
regulated protein kinase (ERK), eventually leads to gene regulation
through the modiﬁcation of transcription factors (Dailey et al., 2005;
Powers et al., 2000; Tsang and Dawid, 2004).
The importance of Fgf8 signaling in multiple developmental
processes is highly conserved across species as revealed by severe
brain and cardiac defects in Fgf8-deﬁcient and tissue-speciﬁc mouse
mutants (Frank et al., 2002; Macatee et al., 2003; Meyers et al., 1998;Park et al., 2006). In zebraﬁsh,mutations in Fgf ligand genes have shown
the importance of these factors in cell survival, migration, and
patterning (Draper et al., 2003; Herzog et al., 2004; Reifers et al.,
1998; Yamauchi et al., 2009). Due to the wide-ranging biological
importance of FGFs, tight control of the signal is essential to regulate the
many FGF-mediateddevelopmental processes (Thisse and Thisse, 2005;
Tsang and Dawid, 2004). To limit FGF signaling, several feedback
attenuators have been identiﬁed within this pathway, including sef
(Furthauer et al., 2002; Tsang et al., 2002), sprouty (spry) (Furthauer
et al., 2001; Hacohen et al., 1998; Kramer et al., 1999; Nutt et al., 2001;
Tefft et al., 2002) and dusp6 (Kawakami et al., 2003; Tsang et al., 2004).
In addition, Pea3 ETS (E26 transformation-speciﬁc) factors are thought
to function as transcriptional regulators of the pathway that allow
proper signaling levels to be reached and maintained during develop-
ment (Munchberg et al., 1999; Raible and Brand, 2001; Roehl and
Nusslein-Volhard, 2001).
The ETS family of transcription factors is important for cell
proliferation, differentiation, and migration (Kobberup et al., 2007;
Wasylyk et al., 1998). All family members contain the ETS domain, an
85-amino acid winged-helix-loop-helix domain that binds to a core
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contains three members, Polyomavirus enhancer activator 3 (PEA3/
ETV4), Er81 (ETV1), and ETS-relatedmolecule (ERM), also known as ETS-
variant 5 (ETV5) in mouse and human. In zebraﬁsh, due to genome
duplication, two ERM/ETV5 genes exist, erm and etv5, in addition to er81
and pea3 (Kudoh et al., 2001; Roussigne and Blader, 2006). In resting cells
these proteins are folded in an inactive state, but upon ERK phosphor-
ylation undergo a conformational change, allowing the ETS domain to be
exposed for DNA binding and gene transcription (Laget et al., 1996;
O'Hagan et al., 1996; Oikawa and Yamada, 2003; Sharrocks, 2001). With
the exception of Er81, the FGF/RAS/MAPK pathway regulates expression
of Pea3 transcription factors in zebraﬁsh (Roussigne and Blader, 2006).
Several members of the mouse Pea3 ETS proteins have been
characterized, providing some evidence for the role for these transcrip-
tion factors in FGF signaling and development (Brent and Tabin, 2004;
Liu et al., 2003; Luet al., 2009;Maoet al., 2009; Zhang et al., 2009). In this
study, we focused on the role of Pea3 ETS transcription factors in FGF
signaling and embryogenesis in the zebraﬁsh. Ectopic expression of
activated forms of Etv5 induced transcription of dusp6 and sef.
Conversely, depletion of Pea3 ETS proteins by antisense morpholino
injections disrupted the isthmic organiser and heart formation, and
altered left/right patterning. The essential DNA sequence required for
FGF-mediated induction of dusp6 was identiﬁed. Further, the ortholo-
gous region of themouseDusp6 promoter is regulated by Etv4 and Etv5
via conserved ETS sites and is bound by ETV4 in vivo. These results
indicate the importance of ETS factors in relaying FGF signals during
development and provide insights as to how FGF target genes are
regulated.Materials and methods
Zebraﬁsh maintenance, RNA injections, and in situ hybridization
These procedures were performed as described previously (Tsang
et al., 2000)with the followingmodiﬁcations forRNA injections:Wildtype
AB* zebraﬁsh embryos were injected with etv5 (100 pg), etv5:VP16
(75 pg), etv5:EnR (150 pg), or mutated forms of etv5; etv5:T135D, etv5:
T139D, etv5:S142D (50 pg) at the 1–2 cell stage. All mutationswithin Etv5
were generated as described in the QuickChange II Site-directed
Mutagenesis Kit (Stratagene) using the primers: 5′-GGGTTCAAGCC-
CATTGGACCCTCCCTCGGACCCC-3′ (forward etv5:T135D), 5′-
GGGGTCCGAGGGAGGGTCCAATGGCTTGAACCC-3′ (reverse etv5:T135D),
5′-ACTCCTCCCTCGGACCCCGTCTCCCCATGT-3′ (forward etv5:T139D), 5′-
ACATGGGGAGACGGGGTCCGAGGGAGGAGT-3′ (reverse etv5:T139D), 5′-
CCCTCGACGCCCGTCGACCCATGTGTCCCCAGC-3′ (forward etv5:S142D),
5′-GCTGGGGACACATGGGTCGACGGGCGTCGAGGG-3′ (reverse etv5:
S142D). In situ hybridizations were performed as described (Kudoh
et al., 2001). The following antisense riboprobes were generated in this
study; etv5 (Kudoh et al., 2001), erm (Munchberg et al., 1999), pea3
(Brown et al., 1998), fgf3 (Kiefer et al., 1996), fgf8 (Reifers et al., 1998),
dusp6 (Kawakami et al., 2003; Tsang et al., 2004), sef (Tsang et al., 2002),
bmp4 (Hwang et al., 1997), chordin (Schulte-Merker et al., 1997), pax2a
(Krauss et al., 1991), her5 (Bally-Cuif et al., 2000), amhc (Berdougo et al.,
2003), vmhc (Yelon et al., 1999), nkx2.5 (Chen and Fishman, 1996), gata4
(Reiter et al., 1999), scl (Liao et al., 1998), spaw (Long et al., 2003) and
hand2 (Yelon et al., 2000).Immunoﬂuorescence
Whole mount immunoﬂuorescence was performed to detect
monocilia in the Kupffer's vesicle as described (Yamauchi et al., 2009).
Monoclonal acetylated tubulin primary antibody (1:1000; Sigma) and
Cy3-conjugated anti mouse IgG secondary antibody (1:500; Jackson
ImmunoResearch Laboratories) was used in this study.Antisense morpholino injections
Morpholino oligos (MOs)were designed and purchased fromGene
Tools (www.gene-tools.com):
etv5MO sequence, 5′-ATCCGTCCATGTCACCTGGGTCTTC-3′;
etv5/ermMO sequence, 5′-TGCTGGTCATAAAATCCGTCCATGT-3′;
fgf8MO sequence, 5′-GAGTCTCATGTTTATAGCCTCAGTA-3′;
and ContMO sequence, 5′-CCTCTTACCTCAGTTACAATTTATA-3′.
From Open Biosystems (www.openbiosystems.com):
ermMO sequence, 5′-AACCCATCCATGTCGCTTGCTTCTC-3′;
pea3MO sequence, 5′-ATCCATGCCTTAACCGTTTGTGGTC-3′;
ContMO (10 ng), fgf8MO (1–3 ng), single EtsMO (5 ng), 2EtsMO
(2.5 ng of each EtsMO), or 3EtsMO (1.3 ng of each EtsMO) were
injected into AB* or Tg(d2EGFP)pt6 embryos as described (Molina et al.,
2007).
Generation of Dusp6 reporter constructs
Zebraﬁsh Dusp6 promoter sequences were PCR ampliﬁed and
directionally cloned into the pENTR Gateway vector (Invitrogen) with
the following primers:
Forward primers: 5Kb: 5′- CACCGACCGGTAGTGAATTTTGATTTGAAC-3′;
4Kb: 5′-CACCGGCCTAGTCGGCACTCAAACCAGTGA-3′;
3Kb: 5′-CACCACTGTGGCATTACAGTGACAGGCCCG-3′;
2Kb: 5′-CACCCTGCGCAGAAGTTCACTTAGACAGTG-3′;
1Kb: 5′-CACCCCACACTGAACTGAGCTAAACTGAAC-3′;
Reverse primer: Dusp6 Rev: 5′-GGTACCGTGAGACCTTAAAACTGCGG-3′.
The promoter sequences were veriﬁed and subcloned into a
Gateway-modiﬁed pGL3-promoter (Promega) by the Gateway Sys-
tem (Invitrogen). Pea3A and Pea3B mutant reporter constructs were
generated using QuickChange II with: MutA: 5′-CACTCG-
CACTCCTCCGGCCGTCCCGTGAAGCGCCTCTCG-3 ′; MutB: 5′-
CCGCTGATCCGGCGCGGCCCGTCCTTTCCGTTTTTGTG-3,′ underlined se-
quence indicate mutation of the ETS binding site.
A 782 bp fragment of DNA 5′ to the mouse Dusp6 gene was
ampliﬁed by PCR and cloned into pGL3-Promoter. The primers were:
5′-ccctggtaccGTACCGTTGGATTAGCATTTAACACTTCGT (sense,
UCSC genome browser Chr10: chr10:98,725,230)
5′- ccctagatctAGTCTAGCGGCTCTTAATCCTC (anti-sense, UCSC genome
browser Chr10: 98,726,011); upper-case letters indicate genomic
sequence. Ampliﬁcation was performed with Pfx Platinum polymerase
(Invitrogen) and 0.1 µg mouse DNA (C57Bl/6) under manufacturer
conditions. The single reaction product was puriﬁed by Qiaquick spin
column (Qiagen), digested with Acc65I and BglII (New England Biolabs),
and cloned into pGL3-Promoter. Mutagenesis of the conserved putative
PEA3 binding sites 1–3 was performed with a Quick-Change Lightening
Kit (Agilent) with mutagenic oligonucleotides designed by the manufac-
turer (see Supplementary Fig. 5A) and plasmids were sequenced.
Mammalian cell and Xenopus explant cultures and luciferase assays
Human 293 T cells (ATCC) were grown at 37 °C, 5% CO2 in DMEM
(GIBCO) containing 10% FBS, 100U/ml penicillin and streptomycin.
Cells were seeded into 24-well plates and were 70–80% conﬂuence at
the time of transient transfection using FuGene6 (Roche). Each well
received 100 ng of pGL3-Control luciferase reporter, 10 ng of pRL-TK
vector (Promega) encoding Renilla luciferase and increasing amounts
of Pea3/Etv4 (Open Biosystems, Clone ID: 3854349) or Erm/Etv5
(Open Biosystems, Clone ID: 4036564) expression vector. The total
amount of DNA in eachwell was adjusted to 310 ng with pcDNA3. The
cells were harvested after 48 h using Passive Lysis buffer (Promega).
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(25 pg), Dusp6:luc construct (125 pg), and pCMV-Renilla (50 pg) into
each cell. In other experiments, etv5 (50 pg), etv5:VP16 (30 pg) or
etv5:T135D (40 pg) was injected in place of fgf8 RNA. Animal caps
were dissected at stage 8.5 and cultured for 6 h. Animal cap lysates
were prepared from a population of four animal caps. In both cell and
frog assays, luciferase activities were determined using Dual Lucifer-
ase Reporter Assay System (Promega). The data were normalized by
calculating the ratio of ﬁreﬂy luciferase to Renilla luciferase. A two-
sample equal variance T-test using a two-tailed distribution was
applied to analyze the data for statistical signiﬁcance.
Electrophoretic Mobility Shift Assays (EMSA)
5′ labeled biotinylated and standard oligonucleotides (Midland
Certiﬁed) 5′-GTTTGTTTGCACTCCGCT-3′ (forward) and 5′-TTTGTCATTCA-
CAAAAAC-3′ (reverse)wereused to generate biotinylatedand competitor
PCR ampliﬁed Dusp6 promoter. For oligonucleotide competition assays,
18mer Pea3B site competitors were generated:
5′-TCCGGAGCG-GAAATTCCT-3′ (forward)
5′-AGGAATTTCCGCTCCGGA-3′ (reverse).
A random sequence competitor oligonucleotide was generated
using:
5′-CCCTCGACGCCCGTCGACCCATGTGTCCCCAGC-3′ (forward)
5′-GCTGGGGACACATGGGTCGACGGGCGTCGAGGG-3′ (reverse).
GST-Etv5-ETS DNA binding domain protein were expressed in
bacteria (BL21) cells (Invitrogen) and batch puriﬁed with GST-
sepharose beads (Amersham). Biotin labeled DNAwas incubated with
Etv5-ETS protein (10ug) and resolved on a 6% native polyacrylamide
gel. The products were transferred to a nylon membrane, cross-linked
by a UV Stratalinker (Stratagene) and detected with streptavidin-HRP
(Pierce). Competition assays were performedwith unlabeled oligos or
PCR-ampliﬁed Dusp6 promoter at 1- to 500-fold molar excess to
labeled probes.
Chromatin immunoprecipitation (ChIP) assay
Chromatinwas immunoprecipitatedusinga variation of theprotocol
described at http://www.cellsignal.com. Brieﬂy, 100 E9.5 mouse
embryos pharyngeal arch regions 2–6 were dissected, minced into
ﬁne slurry, cross-linked in 2% formaldehyde for 30 min, washed with
ice-cold PBS, pelleted, and re-suspended in 1% NP-40 non-denaturing
lysis buffer with protease inhibitors (Roche, 1-836-153). The chromatin
DNA was digested with micrococcal nuclease (New England Biolabs,
M0247S) for 5 min to generate fragments ranging from 150 to 900 bp
and diluted in ChIP buffer with protease inhibitors. Two percent of the
diluted supernatant was kept as input control. Samplewas incubated at
4 °C overnightwith antibody against Pea3 (Etv4) (Santa Cruz, sc-113X).
A normalmouse IgG (Santa Cruz, sc-2025)was used asnegative control.
Complexes were precipitated with Dynabeads® Pan Mouse IgG
(Invitrogen, 110-41). Immunoprecipitated chromatin was washed,
eluted in elution buffer, incubated at 65 °C for 8 h, and treated with
proteinase K. DNA was puriﬁed by phenol extraction and ethanol
precipitation.
Two different Dusp6 primer sets were employed to determine if the
putative PEA3 binding sites in the Dusp6 promoter were enriched in
chromatin immunoprecipitated with anti-ETV4 antibody relative to
distant sequences at this locus: the “Dusp6 prom” set ampliﬁes the
highly conserved region of the mouse Dusp6 promoter: 5′
AGTGCCCTGGTTTATGTGC 3′ (chr10: 98,725,599-98,725,618, sense), 5′
CGGGAGGAAGGAGAAAGAA 3′ (chr10: 98,725,599-98,725,618, anti-
sense). The “Dusp6 neg” negative control primer set ampliﬁes a non
conserved region5′ to theDusp6gene: 5′AAGGCCGAGGAAAAGACTTC3′(chr10: 98,721,292-98,721,311, sense,), 5′ ACCCGTGTTACTGGAGATCG′
(chr10: 98,721,426-98,721,445, anti-sense). An additional negative
control primer set was employed that ampliﬁes a region upstream of β-
actin gene: 5′ GTGCTTAAGAGTCCACTATGAGGG3′ (sense), 5′
TCCACTCGCAATCATATACTTAGG3′ (anti-sense). Equal quantities of
input and immunoprecipitated DNA samples were subject to PCR (35
cycles), electrophoresed on a 2% agarose gel and visualized by ethidium
bromide staining.
To quantitate the enrichment of the Dusp6 promoter region in the
ChIPed region, quantitative PCR was performed in the Bio-Rad iCycler
IQ™ Multicolor Real-Time PCR Detection System using 25 µl IQ™
SYBR® Green Supermix (Bio-Rad, 170-8882), 250 nM of each primer
and 2 μl of immunoprecipitated and input DNA samples. The
ampliﬁcation ramp included an initial hold of 5 min at 94 °C, followed
by a three step cycle consisting of denaturation at 94 °C (30 s),
annealing at 57 °C (30 s) and extension at 72 °C (30 s); the
ampliﬁcation ﬂuorescence was read at the end of the cycle. The Ct
values and standard deviations were analyzed using a method modi-
ﬁed from that of SuperArray Biosciences: (http://www.workingth-
ebench.com/search/label/chromatin%immunoprecepitation). This
protocol correctly propagates the standard errors in the PCR data and
permits quantitation of the Dusp6 target amplicon in the ETV4 ChIPed
sample relative to that ChIPed by a nonspeciﬁc antibody (normalized to
the actin negative control amplicon to control for total DNA quantity in
each sample), and expressed as a percent of amplicon detected in the
input sample. The enrichment was nearly 7-fold and this was highly
reproducible over multiple ChIP experiments with this tissue.
Results
Pea3 ETS transcription factors can induce FGF target gene expression
Amino acid alignment between the three Pea3 ETS transcription
factors shows high sequence conservation, especially within the DNA
binding domain and their developmental expression overlaps with
each other and with fgf8 and fgf3 (Supplementary Fig. 1A–G) (Raible
and Brand, 2001; Roehl and Nusslein-Volhard, 2001; Roussigne and
Blader, 2006). Er81 expression is not limited to the domains where fgf
ligands are expressed and suppression of FGF signaling does not affect
Er81 expression. It is likely that Er81 has evolved in zebraﬁsh to serve a
separate function that is distinct from its orthologs in mouse and
Xenopus laevis and therefore, Er81was not examined in these studies.
Sequence conservation and similar expression pattern suggest that the
three ETS factors may perform redundant functions. To determine if
Pea3 ETS factors can regulate FGF signaling, we employed gain-of-
function studies with etv5. Microinjection of etv5 mRNA into the 1–2
cell stage embryo did not evoke discernable phenotypes or induce the
FGF target genes dusp6 and sef (Fig. 1A, B, F, G, U). In support of these
ﬁndings, dorsal-ventral patterning as determined by expression of
bmp4 (Fig. 1K, L, U) and chordin (Fig. 1P, Q, U) was unaffected. Similar
results were observed after injection of erm or pea3mRNA, suggesting
that the ectopically expressed factors were non-functional (not
shown). The lack of phenotype noted in etv5-injected embryos was
likely due to the auto-inhibitory domain located within the amino
terminus of Pea3 proteins that suppresses DNA binding (Supplemen-
tary Fig. 2A) (Laget et al., 1996; O'Hagan et al., 1996). To overcome this
inhibition, the Etv5-ETS domain was fused to the VP16 transcriptional
activation motif (etv5:VP16) (Supplementary Fig. 2B). Ectopic expres-
sion of etv5:VP16 greatly induced dusp6 and sef expression (Fig. 1C, H,
U) and exhibited dorsalized phenotypes (not shown). bmp4 expres-
sion was diminished while chordin was increased in etv5:VP16-
injected embryos (Fig. 1M, R, U). The Pea3 proteins act as transcrip-
tional activators and fusion of an Engrailed transcriptional repressor
(EnR) domain was used to generate a dominant negative protein
(Brent and Tabin, 2004; Liu et al., 2003). Injection of etv5:EnR resulted
in ventralized phenotypes (not shown), and expression of dusp6 and
Fig. 1. Etv5 functions as a positive effector in FGF signaling. (A–O) Lateral views and (P–T) animal views at shield stage. In situ probes and constructs injected are indicated on the left
and above, respectively. Expression of downstream targets of FGF signaling, dusp6 and sef, are unaltered in etv5-injected embryos (B, G), but were induced by etv5:VP16 mRNA
injections (C, H). Ectopic expression of dominant negative (etv5:EnR) blocks dusp6 and sef expression (D, I). Injection of etv5:T135D increased dusp6 and sef expression (compare A, F
to E, J). Expression of bmp4 and chordin was unchanged in etv5-injected embryos (L, Q). A dorsalized phenotype was noted in etv5:VP16-injected embryos (M, R) and a ventralized
phenotype upon etv5:EnR mRNA injection (N, S). Injection of etv5:T135D mRNA evoked dorsalized phenotypes (O, T). (U) Frequency of phenotypes elicited by microinjection of
mRNAs indicated.
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was expanded with the concomitant reduction in chordin transcripts
(Fig. 1N, S, U). These results indicated that Etv5 was capable of
regulating FGF target gene expression.
The DNA binding activity of ERM/ETV5 is regulated by ERK2
phosphorylation (Laget et al., 1996; O'Hagan et al., 1996). We
identiﬁed a series of conserved putative ERK phosphorylation motifs
(PXS/TP) in zebraﬁsh Etv5 and Erm (Supplementary Fig. 2C). Todetermine the importance of these residues, we individually mutated
T135, T139, and S142 residues to aspartic acid to mimic phosphor-
ylation (etv5:T135D, etv5:T139D, and etv5:S142D). Injection of etv5:
T135D mRNA induced both dusp6 and sef expression similar to the
results obtained with etv5:VP16 injections (Fig. 1E, J, U). As predicted,
bmp4 expression was suppressed while chdwas expanded, indicating
strong dorsalization (Fig. 1O, T, U). Dorsalized phenotypes were also
noted in etv5:T139D- and etv5:S142D-injected embryos (Fig. 1U). We
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residue 100 and ectopic expression of pea3:S100D resulted in
dorsalized phenotypes and expanded the expression of FGF target
genes (not shown) (Guo and Sharrocks, 2009). These experiments
indicate that Etv5 and Pea3 are transcriptional regulators of FGF target
genes and that their transcriptional activity could be controlled by
ERK phosphorylation.
Pea3 ETS factors are required for FGF signaling
To determine the requirement of Pea3 ETS factors for FGF-mediated
developmental processes, we generated antisense morpholinos (MOs)
that blocked translation of members of the Pea3 ETS genes. Each
antisenseMO targeted the AUG codon of etv5, erm, or pea3, and oneMO
that targeted both etv5 and erm (etv5/ermMO), given the high degree of
identity between these two genes. To conﬁrm MO speciﬁcity, embryos
were co-injectedwithMOs and a construct containing theMO targeting
site fused to enhanced green ﬂuorescent protein (EGFP; Supplementary
Fig. 3A). At the shield stage, each individual MO suppressed expression
of its respective Ets-EGFP fusion protein and not the other related
constructs (Supplementary Fig. 3B and C), indicating that theMOswere
effective and speciﬁc. Targeted depletion of Pea3, Erm or Etv5
individually did not result in discernable phenotype at 28hpf (not
shown). In contrast the knock-down of all three genes (herein referred
to as 3EtsMO) resulted in mid–hindbrain (MHB) defects similar to the
fgf8 zebraﬁsh mutant, acerebellar (ace) (Fig. 2B) (Picker et al., 1999;
Reifers et al., 1998). These results suggest that Pea3 ETS transcription
factors are functionally redundant. dusp6 expression in 3EtsMO-injected
embryos was reduced in the MHB at 28hpf, suggesting that Pea3 ETS
factors are required to mediate FGF signaling in the MHB (Fig. 2H). We
conﬁrmed that these factors function redundantly as microinjection ofFig. 2. The Pea3 ETS factors perform redundant functions and are required for mid–hind
antisense morpholinos targeting pea3, erm and etv5 (3EtsMO) resulted in MHB defects (B) as
be rescued by co-injection ofHAetv5 orHApea3mRNA (D–F) but not by GFPmRNA (C). Expre
HApea3 rescued dusp6 expression (I). Red arrowhead marks loss of MHB in MO-injected emMO-resistant etv5 (HAetv5) or pea3 (HApea3) mRNA rescued the MHB
phenotype and dusp6 expression (Fig. 2D–I; 73% rescued with HAetv5,
n=71 and 66% rescued with HApea3, n=44). Furthermore, the co-
injection of HAetv5 and HApea3 mRNA together did not result in an
additive or synergistic rescue of 3EtsMO morphants, suggesting that
either gene can compensate for the loss of the other (Fig. 2F, I; 69%
rescue, n=56). These data suggest that Pea3 ETS factors function
redundantly and are required for FGF signaling.
The depletion of pea3, erm, or etv5 alone did not alter dusp6 or sef
expression at shield stage (Fig. 3A, B, E, F, Q and data not shown).
However, the knock-down of both etv5 and erm did result in a mild
suppression of these FGF target genes (Fig. 3C, G, Q). In contrast, the
concerted depletion of all three factors dramatically diminished both
dusp6 and sef expression, even with lower concentrations of MO
injected for each target (Fig. 3D, H, Q). At 28hpf, single or two ETS (erm
and etv5 herein referred to as 2EtsMO) knockdown displayed minimal
reduction of her5 and pax2a expression in theMHB (Fig. 3J, K, N, O, Q). In
contrast, depletion of all three family members strongly suppressed
expression of these genes (Fig. 3L, P, Q). These loss-of-function studies
further emphasized functional redundancy within the Pea3 ETS family.
Our experiments indicated that the reduction of one Pea3 ETS family
member was not sufﬁcient to generate discernable phenotypes, but the
knockdown of three Pea3 ETS genes resulted in an inhibition of FGF
signaling and evoked defects similar to that of fgf8mutants, suggesting
the importance of Pea3 ETS factors within this signaling cascade.
A role for Pea3 ETS factors maintaining cardiac progenitors
In mice, altering gene dosage of Fgf8 or the source of Fgf8 protein
demonstrated a role for Fgf8 in cardiovascular development (Abu-Issa
et al., 2002; Frank et al., 2002; Macatee et al., 2003; Meyers and Martin,brain boundary (MHB) formation. (A–I) Lateral views of 28hpf embryos. Injection of
compared to the Control scrambled morpholino (A). 3EtsMO-induced MHB defects can
ssion of dusp6 is diminished in 3EtsMO-injected embryos (H). Co-injection ofHAetv5 and
bryos.
Fig. 3. Pea3 ETS factors are required for target gene responses to FGF signaling. (A–P) Lateral views of embryos injected with MOs indicated above and assayed with probes indicated
on the left. Expression of FGF target genes, dusp6 and sef, were unchanged in etv5MO-injected embryos (B, F). In contrast, the double or triple knockdown of Pea3 ETS genes elicited a
drastic reduction of dusp6 and sef (C, D, G, H). Knockdown of Pea3 ETS genes resulted in MHB defect as measured by her5 (I–L) and pax2a (M–P) expression. Individual knock-down
had minimal effects, while 3EtsMO injections resulted in dramatic reduction of her5 (L) and pax2a (P). (Q) Graph depicting the phenotypic effects of etv5MO, 2EtsMO and 3EtsMO on
expression FGF target genes and MHB markers. Red arrowhead marks loss of MHB gene expression.
16 W.A. Znosko et al. / Developmental Biology 342 (2010) 11–251999; Park et al., 2006).More recently, conditional ablation of Fgf8 and Fgf
receptors with different Cre driver lines revealed that Fgf8 regulates
expression of Pea3/Etv4 and Erm/Etv5 in heart precursors and is required
for outﬂow tract formation (Ilagan et al., 2006; Park et al., 2006; Park et al.,
2008). These studies determined the temporal and spatial role for Fgf8
derived from both the endoderm and mesoderm for proper
morphogenesis of the heart, and showed that Fgf8 is required for
proliferation and survival of cardiac progenitors (Ilagan et al., 2006; Park
et al., 2006). FGF signaling in zebraﬁsh isnecessary to specify andmaintain
cardiacprogenitor cells during somitogenesis stages (Marqueset al., 2008;
Molina et al., 2009; Reifers et al., 2000). Based on previous fate mappingstudies in zebraﬁsh, we observed expression of pea3, erm, and etv5 in the
zebraﬁsh anterior lateral plate mesoderm (ALPM), suggesting that these
factorsmayplay a role inestablishingandmaintaining cardiacprogenitors
during somitogenesis stages (not shown) (Lee et al., 1994; Stainier et al.,
1993). Injection of etv5MOmildly reduced expression of a cardiac speciﬁc
transcription factor, nkx2.5 (Fig. 4A, B, Y). However, injection of 2EtsMO or
3EtsMOmarkedly reduced this cardiac population, a phenotype that was
similar to fgf8MO-injected embryos or in acemutants (Fig. 4C–F, Y).Gata4,
a gene expressed throughout theALPM,was also reduced in both 2EtsMO-
and 3EtsMO-injected embryos, and was comparable to fgf8-deﬁcient
embryos (Fig. 4G–L, Y) (Draper et al., 2001; Marques et al., 2008;
17W.A. Znosko et al. / Developmental Biology 342 (2010) 11–25Serbedzija et al., 1998). We next analyzed expression of hand2, a marker
for lateral cardiac progenitors in the ALPM (Yelon et al., 2000).
Complimentary to the observed reduction of nkx2.5+ cells, hand2
expression was also reduced with knock-down of multiple Pea3 factors
(Fig. 4M–R, Y).
Within the ALPM, an important interplay between the hematopoi-
etic/vascular cells and cardiac progenitors exists to maintain the size of
both populations (Keegan et al., 2004; Schoenebeck et al., 2007). We
analyzed scl expression at the 10-somite stage in 3EtsMO-injected
embryos to determine if these factors play a role in endothelial lineagesFig. 4. Pea3 ETS factors are required to maintain cardiac progenitors. (A–X) Dorsal views at 1
reduced asmultiple Pea3 factors were knocked down (D). This was similar to fgf8MO knock-d
(M–P) were also reduced after Pea3 depletion (J, P). A similar phenotype was observed in fg
indicated expansion of endothelial lineages in EtsMO injections (T–V) as indicated by arrowh
fgf8MO and ace embryos suggesting that FGF signaling is required to maintain cardiac proge
quantitative data for MO experiments.within the ALPM. Knock-down of Pea3 ETS factors resulted in an
expansion of scl expression at the 10-somite stage (Fig. 4S–V, Y). Most
strikingwas that the depletion of etv5 alonewas sufﬁcient to expand scl
populations, indicating that this precursor population is particularly
sensitive to Etv5 activity (Fig. 4T). Similar MO injections against only
erm or pea3 had no effect on scl expression, indicating the importance of
a single, speciﬁc ETS family member, etv5, in restricting endothelial
domains within the ALPM (data not shown). Injection of 2EtsMO or
3EtsMO elicited stronger expansionof hematopoietic andvessel lineages
as also noted in fgf8-depleted or ace embryos, implicating that the loss of0-somite stage. In situ probe listed on left and MO above. (A–D) nkx2.5 expression was
own and in acemutants (E–F). (G–J; M–P) gata4 expression (G–J) and hand2 expression
f8MO knock-downs and in ace mutants (K, L;Q, R). (S–V) Dorsal view of scl expression
eads that mark the caudal limit in uninjected embryos (S). Similar results were noted in
nitors and to limit endothelial lineages to the rostral ALPM (W, X). (Y) Graph providing
18 W.A. Znosko et al. / Developmental Biology 342 (2010) 11–25FGF signaling expanded endothelial lineages (Fig. 4W–Y). Taken
together, these data provided evidence that Pea3 ETS factors are
required to maintain cardiac progenitors within the ALPM.
Pea3 ETS factors function in Left/Right (L/R) patterning of the heart
We next determined if the loss of cardiac progenitors at early
somitogenesis stages resulted in later heart defects. We assayed
expression of two speciﬁc cardiac differentiation markers at 24hpf,
ventricular myosin heavy chain (vmhc) for ventricular tissue, and for
atria, atrial myosin heavy chain (amhc) (Berdougo et al., 2003; Yelon
et al., 1999). In etv5MO-injected embryos, amhc was expressed in a
population of cells just below the left eye (Fig. 5B), resemblingFig. 5. Pea3 ETS factors are required for heart development. (A–L) In situ hybridization show
Pea3 ETS factors altered amhc (D; red arrowhead indicates midline of embryo) and vmhc exp
was severely affected in 3EtsMO-injected embryos as shown by expression of cmlc2 (K, L). (M
normal looping, K; no looping, L; reverse looping.observations in control scrambled morpholino (ContMO)-injected
embryos (Fig. 5A). In the 2EtsMO and 3EtsMO-injected embryos, diffuse
amhc staining was noted at the midline, suggesting disruption of heart
tube morphogenesis (Fig. 5C, D). In ContMO- and etv5MO-injected
embryos, vmhc expression outlined the heart tube as it “jogged” to the
left (Fig. 5E, F). However in 2EtsMO- or 3EtsMO-injected embryos,
ventriclemorphologywas altered andwaspredominantly located at the
midline between the eyes, suggesting a L/R patterning defect (Fig. 5G,
H). Analysis of cardiac myosin light chain 2 (cmlc2) expression at 48hpf
revealed disruption of cardiac looping in 3EtsMO-injected larvae,
resulting in either non-looping straight hearts or reversed looping
hearts (Fig. 5L, M; 50% n=97). These data suggested that Pea3 ETS
factors are required for proper heart morphogenesis and likely to relaying cardiac gene expression at 24hpf (A–H) and 48hpf (I–L). Knock-down of multiple
ression (H; cell population and spatial arrangement in yellow bracket). Cardiac looping
) Quantiﬁcation of effects on heart looping in MO-injected embryos as exempliﬁed in I;
19W.A. Znosko et al. / Developmental Biology 342 (2010) 11–25Fgf8, Fgf24 and Fgf4 signaling to establish L/R asymmetry (Neugebauer
et al., 2009; Yamauchi et al., 2009).
Given the L/R patterning defects we observed in the knock-down of
Pea3 ETS factors,wenext investigated their role in Kupffer's vesicle (KV)
formation. TheKV is a transientﬂuidﬁlled organderived fromthedorsal
forerunner cells that plays a critical role in establishing L/R polarity
(Cooper and D'Amico, 1996; Essner et al., 2005; Kramer-Zucker et al.,
2005; Melby et al., 1996; Okabe et al., 2008). We have generated a
transgenic reporter line Tg(dusp6:d2EGFP)pt6 that expresses GFP in
response to FGF signaling (Molina et al., 2007). In transgenic embryos,
GFP is detected in the dorsal forerunner cells and in KV, indicating that
FGF signaling is active in these cells. Injection of 3EtsMO into Tg(dusp6:
d2EGFP)pt6 embryos resulted in decreased GFP ﬂuorescence within the
MHB, rhombomere 4 and KV, suggesting that Pea3 ETS proteins are
required for GFP reporter gene expression (Fig. 6B). Although GFP
expression was extinguished in the KV, the vesicle did form (Fig. 6B′).
Therefore, FGF signaling is not required for KV formation. Recent studies
have shown a role for FGF signaling in ciliogenesis, especially in the KV
(HongandDawid, 2009;Neugebauer et al., 2009; Yamauchi et al., 2009).Fig. 6. Pea3 ETS factors are required for ciliogenesis in the Kupffer's vesicle and subsequen
normal formation of Kupffer's vesicle, even though FGF signaling was suppressed (B, B′). (C
stage. (E) Graph showing average number of cilia in MO-injected embryos. Expression of sp
depicting L/R defects in Pea3 ETS and Fgf8 depleted embryos.Cilia are required for proper L/R patterning and disrupting their
formation or function randomizes L/R polarity. Thus one hypothesis
was that cilia number could be affected in Pea3 ETS depleted embryos.
Analysis of cilia in the KV of 3EtsMO-injected embryos revealed a
signiﬁcant decrease in cilia number (Fig. 6C, D, E; p=5.21×10−8). To
determine if L/R patterning was affected at late somitogenesis stages,
we analyzed expressionof spaw, a gene that is normally expressed in left
lateral plate mesoderm (Long et al., 2003). spaw expression was often
absent, bilateral or right-sided in 3EtsMO-injected embryos, consistent
with disruption of upstream initiation of the L/R cascade (Fig. 6F–J). In
addition, expression of foxj1a, a transcription factor shown to be
involved in ciliogenesis was reduced or absent in 3EtsMO-injected
embryos, implicating the importance of ETS transcription factors in cilia
formation (Supplementary Fig. 4A, B; 33% with reduced foxj1a n=112)
(Bonnafe et al., 2004; Brody et al., 2000). A recent study shows a similar
decrease in foxj1a expression in Fgfr1 depleted embryos (Neugebauer
et al., 2009). Thus Pea3 ETS factors are required to relay FGF signaling
downstream of multiple ligands to maintain foxj1a expression, a
prerequisite of ciliogenesis.t L/R patterning. (A, B) Tg(dusp6:EGFP)pt6 embryos injected with 3EtsMO show grossly
, D) Cilia number in the KV was reduced in 3EtsMO-injected embryos at the 12-somite
aw in 3EtsMO-injected embryos reveals L/R defects at 18-somite stage (F–I). (J) Graph
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We next determined if FGF target genes contain Pea3 ETS binding
sites. For this purpose we analyzed the Dusp6 promoter and utilized
Xenopus laevis explant luciferase assays to identify regulatory elements
within its upstream promoter sequence. A 10-kb sequence upstream of
Exon 1 in Dusp6 is sufﬁcient to drive reporter expression in an FGF-
dependent manner (Molina et al., 2007). Luciferase reporter constructs
containing varying lengths of upstream sequence (5Kb to 1Kb)were co-
injected into each cell of a 2-cell stage Xenopus embryo together with
fgf8mRNA(Fig. 7A). A 3-fold increase in luciferase activitywas observed
in the presence of Fgf8 (nN4 for each construct, Fig. 7B and data not
shown). Since these results indicated the presence of FGF responsive
elementswithin 1Kb upstreamof the transcription start site, we aligned
this genomic region from several species. Signiﬁcant homology was
identiﬁed among all four vertebrate promoters studied, consistent with
a recent report (Fig. 7C) (Ekerot et al., 2008). Several putative
transcription factor binding sites were found, including two sites for
Pea3 ETS proteins, Pea3A and Pea3B, that were also described in the
mouseDusp6 promoter (Fig. 7C) (Ekerot et al., 2008).Wemutated these
putative Pea3 binding sites and found that the Pea3B site, which
contains three perfectly conserved core 5′-GGAA3′ motifs, was critical
for the FGF-mediated induction of luciferase activity (Fig. 7B, C; MutA
and MutB, sequences of the mutations in red). To determine if Etv5 can
regulate theDusp6 promoter directly, we injected etv5:VP16with either
a wildtype 2.2Kb Dusp6 reporter or a Pea3 mutant reporter construct
(MutA or MutB). Ectopic expression of etv5:VP16 caused a dramatic
increase in luciferase activity with the wildtype and MutA Dusp6
reporters, whereas the MutB reporter exhibited little induction
(Fig. 7D). Furthermore, etv5:T135D increased luciferase activity and
was dependant on the Pea3B sequence (Fig. 7E). These results indicated
that FGF signaling directly regulates Dusp6 transcription through the
activity of Pea3 ETS factors.
To determine if Pea3 ETS factor function is conserved between
zebraﬁsh and mouse, we co-transfected mouse Etv4 or Etv5 expression
plasmids with the zebraﬁsh reporter constructs into 293 T cells. Both
ETV4 and ETV5 were capable of inducing reporter gene expression in
293 T cells, and this was dependent on the Pea3B site in 293 T cells
(Supplementary Fig. 5). Furthermore, we isolated the mouse Dusp6
promoter and generated luciferase reporter constructs with 0.6Kb of
upstream promoter sequence. Ectopic expression of mouse ETV4 or
ETV5 transactivated the promoter, and this activity was also dependent
on the exact Pea3B sequence found in the zebraﬁsh Dusp6 promoter
(Supplementary Fig. 6). These results reveal the evolutionary conser-
vation of Pea3ETS factors asproteins fromeithermouse or zebraﬁsh can
activate reporter gene expression driven by either promoter.
Pea3 ETS protein directly binds to the Dusp6 promoter
Using electrophoretic mobility shift assays (EMSAs) in vitro and by
chromatin immunoprecipitation (ChIP) assays in vivoweaskedwhether
Pea3 ETS factors could bind to the Dusp6 promoter. We generated
biotin-labeled oligos that ﬂank the Pea3B site (60 bp) and ampliﬁed this
region by PCR (Fig. 8A). Recombinant GST-Etv5:ETS domain protein
interacted with the biotin-labeled Dusp6 promoter DNA (Fig. 8D; lane
2). The bound DNAwas competed by increasing amounts of non-biotin
labeled promoter (Fig. 8D; lanes 3–7). Likewise, the Pea3B-18mer oligo
(Fig. 8C) also competed Etv5 binding (Fig. 8D; lanes 8–12), while a
random sequence used as control competitor did not compete with the
biotin-labeled Dusp6 fragment (Fig. 8D; lanes 13–17). To verify the
importance of the Pea3B site for Etv5 binding, a 60 bp biotin-labeled
Pea3B mutant Dusp6 promoter was used in EMSAs (Fig. 8B). Etv5-ETS
protein did not shift the Pea3B mutant DNA (Fig. 8D; lanes 18, 19).
To determine if Pea3 ETS factors can directly bind to the mouse
Dusp6 promoter in vivo, we performed ChIP assays on isolated
pharyngeal tissue from E9.5 mouse embryos, a region with active FGFsignaling that expresses high levels of Etv4, Etv5 and Dusp6 (Dickinson
et al., 2002; Ilagan et al., 2006; Park et al., 2006). By ChIP and PCR, we
found that the Pea3B binding site was enriched with speciﬁc ETV4
antibodies, suggesting that ETV4directly binds to theDusp6promoter in
vivo (Fig. 9A–C). qPCR quantitation revealed a 7-fold enrichment of this
element in the ETV4 ChIPed sample compared to negative control
(Fig. 9D). Taken together, we show that Dusp6 is directly regulated by
Pea3 ETS factors during zebraﬁsh and mouse embryonic development.
Discussion
The role of Pea3 ETS factors in FGF-mediated developmental processes
In this report we show that Pea3 ETS factors function to mediate
the transcriptional response in the FGF pathway to directly activate
dusp6 expression. We have identiﬁed putative ERK phosphorylation
sites in Etv5 and show that introducing phosphomimetic mutations
into these sites resulted in constitutively active ETS transcription
factors. A similar putative MAPK phosphorylation site was identiﬁed
in Pea3, suggesting that all three factors are regulated by the FGF/
RAS/MAPK pathway (Guo and Sharrocks, 2009). Antisense MO
injections blocking the translation of erm, etv5, and pea3 resulted in
an MHB defect in the zebraﬁsh embryo, as well as suppression of FGF
target genes. The importance of these ETS factors in heart develop-
mentwas revealed by the loss of cardiac progenitors in Pea3 ETS factor
depleted zebraﬁsh embryos, consistent with a critical role for these
factors downstream of FGFs in mice. In zebraﬁsh, experimental
manipulations that expand cardiac progenitors negatively affected
the blood and vessel lineages, and vice versa (Molina et al., 2009;
Schoenebeck et al., 2007). Given that Fgf8 and Pea3 ETS factors play an
important role in maintaining cardiac identity, we reasoned that the
knock-down of Pea3 ETS factors might expand endothelial lineages.
Indeed, the concerted depletion of Pea3 ETS factors resulted in an
increase in blood and vessel progenitors as marked by expanded scl
expression. Interestingly, one ETS factor, Etv5, was shown to be critical
to repress scl expression, indicating that, although Pea3 ETS factors
appear to function redundantly in most FGF-mediated developmental
processes, this speciﬁc factor appears to be solely responsible to
restrict endothelial expansion within the ALPM. Thus, FGF activity is
required to maintain cardiac progenitor populations and suppress
endothelial differentiation within the caudal domain of the ALPM.
Studies have highlighted a role for FGF signaling in L/R patterning
of the zebraﬁsh embryo (Albertson and Yelick, 2005; Hong and Dawid,
2009; Neugebauer et al., 2009; Yamauchi et al., 2009). The knock-
down of either Fgf ligands or two effectors of the FGF pathway did not
disturb formation of the KV, but did disrupt motile cilia formation
(Hong and Dawid, 2009; Neugebauer et al., 2009; Yamauchi et al.,
2009). In this study, depletion of Pea3 ETS factors did not disrupt KV
formation, but cilia numberwasmarkedly reduced. This is responsible
for the laterality defects such as alteration of lateral spaw expression
and both the cardiac jogging and looping defects. Interestingly, among
these studies, the role of FGF signaling in proper motile cilia formation
within the KV has ranged from contributing to cilia length
(Neugebauer et al., 2009; Yamauchi et al., 2009) to contributing to
the total number of motile cilia in the KV (Hong and Dawid, 2009).
Because of this, it can be hypothesized that the speciﬁcity in
patterning of KV motile cilia may involve several different Fgf ligands
and/or transcription factors. In this study, we have revealed a role for
Pea3 ETS transcription factors in ciliogenesis within KV.
Pea3 ETS factors directly bind to the Dusp6 promoter in vivo
How FGF signaling is relayed into a transcriptional response in
development is not fully deﬁned. BecauseDusp6 is a known target of FGF
activity, we focused on identifying cis-elements within the Dusp6
promoter to determine if Pea3 ETS factors can directly regulate its
Fig. 7. fgf8 and etv5 activates Dusp6 promoter. (A) Diagram showing the Dusp6 promoter assay in Xenopus animal caps. (B) Luciferase activity measured with 2 kb Dusp6 promoter
(WT) constructs in the presence or absence of fgf8, indicating the requirement for the Pea3B site (MutB). (C) Alignment of Dusp6 promoter from several vertebrate species showing
conserved putative ETS binding sites (highlighted in purple) that were mutated as shown in red below the sequence. (D) etv5:VP16 could activate the Dusp6 reporter (WT), and
mutation of the Pea3B (MutB) site diminished this activity. (E) Ectopic expression of etv5:T135D activated the Dusp6 reporter (WT), but not the mutant Pea3B reporter (MutB).
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Fig. 8. Etv5-ETS domain binds to the Dusp6 promoter. (A) Biotin labeled PCR product. (B) Biotin labeled mutant Pea3B Dusp6 promoter fragment. (C) Pea3B 18 bp fragment used in
competition assays. Underlined sequence represent the putative Pea3B binding site (D) EMSA using 60 bp Dusp6 promoter biotin fragment and GST-Etv5:ETS protein. The Etv5-ETS
domain bound to the 60 bp Dusp6 promoter containing the Pea3B site (lane 2). This binding was competed with the non-biotin labeled 60 bp Dusp6 promoter (lanes 3–7) and the
Pea3B 18 bp fragment (lanes 8–12). A random oligonucleotide sequence did not compete this binding (lanes 13–17). Binding of Etv5-ETS to the Pea3B mutant Dusp6 promoter was
not observed (lanes 18–19).
22 W.A. Znosko et al. / Developmental Biology 342 (2010) 11–25transcription (Molina et al., 2007; Tsang et al., 2004). We identiﬁed
several conserved putative ETS binding siteswithin theDusp6promoter
and through reporter and binding assays we indentiﬁed one particular
site that was critical for reporter gene activity and in vitro binding. This
site is identical to what has been recently described in mouse Dusp6
promoter (Ekerot et al., 2008). Ekerot et al., (2008)haddemonstrated by
ChIP studies in NIH3T3 cells that both Ets1 and Ets2 can bind to this
particular region. Our studies demonstrate for the ﬁrst time that Pea3
can bind to theDusp6promoter in vivo and provide strong evidence that
FGF signaling regulates Dusp6 transcription by Pea3 ETS factors during
development. These differencesmay reﬂect varying expression levels of
these ETS factors between NIH3T3 cells and mouse pharyngeal tissue.
Since Fgf8, Etv4, Etv5 and Dusp6 are strongly expressed in pharyngeal
arch, our results provide strong evidence for the direct binding of ETV4
to the Dusp6 promoter (Dickinson et al., 2002; Ilagan et al., 2006; Park
et al., 2006). In contrast, both Ets1 and Ets2 transcripts are predomi-
nantly expressed in vascular and lymphatic tissues and not co-
expressed with Dusp6 (Maroulakou et al., 1994). However, in NIH3T3
cells, expression of Ets1 and Ets2 may play a greater role in regulating
Dusp6 expression in vitro.
Redundant function of Pea3 ETS transcription factors during development
Etv5 or Etv4 gene knock-out approaches in mice resulted in
developmentally normal animals that survived to adulthood, butdevelopedmotor neuron differentiation defects, spermatogonial stem
cell renewal defects, and movement disorders (Arber et al., 2000;
Chen et al., 2005; Livet et al., 2002). The lack of gross developmental
phenotypes in these knock-out mice suggested these genes may
function redundantly in mediating FGF signaling. To circumvent
redundancy among Pea3 factors, engrailed repressor fusion constructs
were ectopically expressed in both mouse and chick embryos (Brent
and Tabin, 2004; Liu et al., 2003). The repression of multiple Pea3 ETS
family members using this technique overcame redundancy to show a
role for these factors in somite and lung development (Brent and
Tabin, 2004; Liu et al., 2003). Further evidence of their redundant
function was shown by ectopic expression of a dominant negative
version of Etv5 in the mouse limb which resulted in shortened limbs
and polydactyly (Mao et al., 2009). This was conﬁrmed by the knock-
out of both Etv4 and Etv5 in early mesodermal lineages that also
resulted in limb and digit defects (Zhang et al., 2009). In our studies,
antisense morpholinos allowed the targeted depletion of multiple
members of the Pea3 family. In general, knocking down only one
member of this family rarely resulted in developmental defects, but
the knock-down of two or three members resulted in distinct
phenotypes.
Functional redundancy within another ETS sub-family of tran-
scription factors in zebraﬁsh has also been described (Pham et al.,
2007). This study examined four ETS familymembers expressed in the
vasculature: ﬂi1, ﬂi1b, ets1, and etsrp (Pham et al., 2007). Using an
Fig. 9. ETV4 directly binds to Dusp6 promoter in vivo in mouse. The mouse Dusp6
promoter region bearing highly conserved PEA3 binding sites is enriched in chromatin
immunoprecipitated from mouse embryonic tissues with anti-mouse ETV4 antibody.
(A) Agarose gel showing PCR products obtained from equal amounts of input, mouse
IgG ChIPed, and anti-ETV4 ChIPed DNAs with the Dusp6 promoter ("Dusp6 prom")
primers that amplify the region containing the putative PEA3 binding sites. (B). Agarose
gel showing PCR products obtained on the same DNA samples as in A with Dusp6
negative control primers. (C) Agarose gel showing PCR products obtained on the same
DNA samples as in A with β-actin negative control primers. Only the Dusp6 promoter
was differentially precipitated by the anti-ETV4 antibody; B and C negative control
primers give identical bands as they detect the non-speciﬁc, background precipitated
DNA. (D) Graphical representation of quantitative PCR results show nearly 7-fold
enrichment of the amplicon containing the highly conserved region of the Dusp6
promoter in ETV4 ChIPed DNA compared to IgG negative control expressed relative to
that detected in input. m, marker; bl, blank lane.
23W.A. Znosko et al. / Developmental Biology 342 (2010) 11–25antisense morpholino approach to knock down expression of all four
genes, both vascular and hematopoietic development was disrupted,
showing the importance of these genes for vessel sprouting and
circulation. Interestingly, a hierarchy was observed, whereby the
knock-down of estrp showed stronger phenotypes than a single
knock-down of ﬂi1, ﬂi1b, or ets1 (Pham et al., 2007). Similarly, a
reduction of etv5was shown in our study to have a strong effect on the
scl expression domain, indicating a hierarchy may also exist between
members of the Pea3 ETS factors. In conclusion, we have deﬁned the
importance of Pea3 ETS transcription factors in mediating FGF
signaling during development.
Our data suggest that in some instances, the knockdown of two Pea3
ETS proteins was sufﬁcient to reveal a phenotype in a majority of theinjected embryos, as noted with the expression of cardiac progenitor
markers, implicating an overlapping function between these factors.
Given that knockdown studies can be difﬁcult to quantitate, a more
effective means is to generate genetic nulls and determine the relative
contribution of each Pea3 ETS factor to FGF signaling and development.
One interesting observation that demonstrates ETS overlapping roles
comes from a recent study in mouse kidney formation. Compound
heterozygotes of two factors (Etv4+/−; Etv5+/−) or Etv4 nulls did
result in a small percentage of embryos showing renal agenesis. In
contrast, Etv4−/−; Etv5+/− mice exhibited a complete lack of
kidneys, suggesting that a full compliment of Etv5 can function to
restore normal kidney development, but in a reduced state, it can not
(Lu et al., 2009). Thus gene dosage may play a critical role in how these
factors bind to promoters and regulate transcription and development.
A more detailed gene expression proﬁling and readout is required to
correlate gene activity with developmental outcome.Acknowledgments
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